- Home
- ZTEK vs ORMP Comparison
ZTEK vs ORMP Comparison
Compare ZTEK & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- ORMP
- Stock Information
- Founded
- ZTEK 2008
- ORMP 2002
- Country
- ZTEK Canada
- ORMP United States
- Employees
- ZTEK N/A
- ORMP N/A
- Industry
- ZTEK Major Chemicals
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- ZTEK Industrials
- ORMP Health Care
- Exchange
- ZTEK Nasdaq
- ORMP Nasdaq
- Market Cap
- ZTEK 91.6M
- ORMP 90.2M
- IPO Year
- ZTEK N/A
- ORMP N/A
- Fundamental
- Price
- ZTEK $0.89
- ORMP $2.31
- Analyst Decision
- ZTEK
- ORMP Hold
- Analyst Count
- ZTEK 0
- ORMP 1
- Target Price
- ZTEK N/A
- ORMP N/A
- AVG Volume (30 Days)
- ZTEK 820.9K
- ORMP 82.5K
- Earning Date
- ZTEK 08-14-2025
- ORMP 11-06-2025
- Dividend Yield
- ZTEK N/A
- ORMP N/A
- EPS Growth
- ZTEK N/A
- ORMP N/A
- EPS
- ZTEK N/A
- ORMP N/A
- Revenue
- ZTEK $678,078.00
- ORMP $2,000,000.00
- Revenue This Year
- ZTEK N/A
- ORMP N/A
- Revenue Next Year
- ZTEK N/A
- ORMP N/A
- P/E Ratio
- ZTEK N/A
- ORMP N/A
- Revenue Growth
- ZTEK 2519.47
- ORMP N/A
- 52 Week Low
- ZTEK $0.50
- ORMP $1.82
- 52 Week High
- ZTEK $1.84
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- ZTEK 56.55
- ORMP 66.88
- Support Level
- ZTEK $0.65
- ORMP $2.17
- Resistance Level
- ZTEK $0.91
- ORMP $2.26
- Average True Range (ATR)
- ZTEK 0.10
- ORMP 0.06
- MACD
- ZTEK 0.03
- ORMP 0.02
- Stochastic Oscillator
- ZTEK 42.77
- ORMP 98.11
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.